Mutations in PI3K/AKT pathway genes were associated with greater UTUC progression (HR 3.29, p = 0.04) and NMIBC recurrence (HR 3.62, p = 0.06). This evidence concerns the gene AKT1 and renal pelvis/ureter urothelial carcinoma.